Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
3
×
detroit blog main
detroit top stories
hepatitis b
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
purdue pharma
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
astrazeneca
diagnostics
gene editing
merck
microbiome
novartis
pfizer
venture capital
What
bio
roundup
drug
abbvie’s
acquisitions
advantages
bar
barbecuing
biggest
brings
build
buy
camping
cardiologist
center
ceo
check
cholesterol
company’s
conference
daniel
day
debut
dyne’s
expect
flop
gamble
gilead
hit
j
j’s
labor
market
medco’s
microbiome
monday
mover
moves
new
openly
Language
unset
Current search:
cancer
×
" hepatitis b "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
